AstraZeneca to invest nearly 200 million yuan in Wuxi drug facility

Verifying
  • AstraZeneca will upgrade its Wuxi development and supply building for a cardiovascular drug.
  • The project covers 5,800 square meters and targets 400 million tablets annually.
  • Operations are scheduled to begin in the fourth quarter of 2029.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
AstraZeneca to invest nearly 200 million yuan in Wuxi drug facility - CoinPost Terminal